Abstract
Lag time in pharmacokinetics corresponds to the finite time taken for a drug to appear in systemic circulation following extravascular administration. Lag time is a reflection of the processes associated with the absorption phase such as drug dissolution and/or release from the delivery system and drug migration to the absorbing surface. Failure to specify the lag time can lead to inappropriate or erroneous estimates of pharmacokinetic parameters. This has been demonstrated in the case of a one-compartment open model by the pharmacokinetic analysis of bioequivalence data from a study involving the administration of propoxyphene napsylate to human volunteers. Subsequently, pharmacokinetic and statistical analyses of data obtained from a series of 49 simulations involving a wide range of absorption and elimination rate constants (0.05 to 5.00 and 0.01 to 0.95 hr−1, respectively) showed that lag time has a substantial effect on several primary and secondary pharmacokinetic parameters.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
M. Gibaldi and D. Perrier. Pharmacokinetics, Marcel Dekker, New York, 1982, pp. 409–416.
M. Bialer. A simple method for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes. J. Pharmacokinet. Biopharm. 8(1):111–113 (1980).
K. K. H. Chan and K. W. Miller. Nonlinear regression approach for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first-order processes. J. Pharm. Sci. 72(5):574–576 (1983).
I. H. Patel. Concentration ratio method to determine the rate constant for the special case when Ka = Ke. J. Pharm. Sci. 73(6):859–861 (1984).
P. E. Macheras. Graphical approach for determining whether absorption and elimination rate constants are equal in the one-compartment open model with first order processes. J. Pharm. Sci. 74(5):582–584 (1985).
P. E. Macheras. Developments in the concentration ratio method. J. Pharm. Sci. 74(9):1021 (1985).
H. P. Wijnand. Pharmacokinetic model equations for the one-and two-compartment models with first-order processes in which the absorption and exponential elimination or distribution rate constants are equal. J. Pharmacokin. Biopharm. 16(1):109–128 (1988).
J. Zhi. Unique pharmacokinetic characteristics of the one-compartment first-order absorption model with equal absorption and elimination rate constants. J. Pharm. Sci. 79(7):652–654 (1990).
J. G. Wagner. Pharmacokinetics, J. M. Richards Laboratory, Grosse Point Park, MI, 1969, pp. 83–84.
M. Rowland. Effects of some physiologic factors on bioavailability of oral dosage forms. In J. Swarbrick (ed.), Current Concepts in the Pharmaceutical Sciences: Dosage Form Design and Bioavailability, Lea & Febiger, Philadelphia, PA, 1973, pp. 190–191.
M. Rowland and T. N. Tozer. Clinical Pharmacokinetics: Concepts and Applications, Lea and Febiger, Philadelphia, 1989, p. 36.
J. Wagner. Fundamentals of Clinical Pharmacokinetics, Drug Intelligence, Hamilton, IL, 1975, pp. 81–82.
R. E. Notari. Biopharmaceutics and Clinical Pharmacokinetics: An Introduction, Marcel Dekker, New York, 1987, p. 122.
L. Shargel and A. B. C. Yu. Applied Biopharmaceutics and Pharmacokinetics, Appleton-Century-Crofts, Norwalk, CT, 1989, pp. 111–112.
W. A. Ritschel. Handbook of Basic Pharmacokinetics, Drug Intelligence, Hamilton, IL, 1986, pp. 10, 454–456.
P. G. Welling and F. L. S. Tse. Pharmacokinetics: Regulatory, Industrial, Academic Perspectives, Marcel Dekker, New York, 1988.
M. Gibaldi. Biopharmaceutics and Clinical Pharmacokinetics, Lea and Febiger, Philadelphia, 1991.
J. G. Wagner. Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence, Hamilton, IL, 1971.
J. Swarbrick. Current Concepts in the Pharmaceutical Sciences: Biopharmaceutics, Lea and Febiger, Philadelphia, 1970.
J. P. Labaune. Handbook of Pharmacokinetics: Toxicity Assessment of Chemicals, Ellis Horwood, Chichester, England, 1989.
S. Niazi. Textbook of Biopharmaceutics and Clinical Pharmacokinetics, Appleton-Century-Crofts, New York, 1979.
R. A. Shipley and R. E. Clark. Tracer Methods for in Vivo Kinetics: Theory and Applications, Academic Press, New York, 1972.
B. N. LaDu, H. G. Mandel, and E. L. Way. Fundamentals of Drug Metabolism and Drug Disposition, Williams and Wilkins, Baltimore, MD, 1972.
A. Rescigno and G. Segre. Drug and Tracer Kinetics, Blaisdell, Waltham, MA, 1966.
D. R. Krishna and U. Klotz. Clinical Pharmacokinetics: A Short Introduction, Springer-Verlag, New York, 1990, pp. 101–149.
A. Akaike. Posterior probabilities for choosing a regression model. Ann. Inst. Math. Stat. 30(A):9–14 (1978).
G. Schwartz. Estimating the dimensionality of a model. Ann. Stat. 6(2):461–464 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nerella, N.G., Block, L.H. & Noonan, P.K. The Impact of Lag Time on the Estimation of Pharmacokinetic Parameters. I. One-Compartment Open Model. Pharm Res 10, 1031–1036 (1993). https://doi.org/10.1023/A:1018970924508
Issue Date:
DOI: https://doi.org/10.1023/A:1018970924508